GUIDELINES FOR MRSA SCREENING IN RELATION TO ELECTIVE SURGICAL ADMISSIONS
|
|
- Joseph Stevens
- 5 years ago
- Views:
Transcription
1 GUIDELINES FOR MRSA SCREENING IN RELATION TO ELECTIVE SURGICAL ADMISSIONS Lead Executive/Director: Sandra Rote, Director of Clinical Development; Executive Lead Nurse; (Director with responsibility for Infection Prevention and Control) Name of originator/author: Carole Clive, Nurse Consultant, Infection Prevention and Control Target audience: Healthcare Staff working in surgical specialities relating to Burlingham Ward, Evesham Community Hospital and Tenbury District and Community Hospital Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 1 of 12
2 CONTENTS 1.0 INTRODUCTION OBJECTIVE/SUCCESS FACTOR LINKS TO OTHER KEY STRATEGIES & POLICIES RESPONSIBILITIES WHO TO SCREEN WHEN TO SCREEN HOW TO SCREEN TREATMENT DOCUMENTATION COMMUNICATION AND PATIENT INFORMATION COMPLIANCE KEY POINTS REFERENCES 6 APPENDIX 1 List Detailing Procedures and Requirement for MRSA Screening 7 APPENDIX 2 Algorithms detailing management 11 Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 2 of 12
3 1.0 INTRODUCTION AND SCOPE In order to ensure the spread of MRSA is minimised, protect patients from infection or colonisation with MRSA and ensure those who are confirmed with MRSA are managed safely and appropriately, certain elective surgical admissions to Evesham Community Hospital and Tenbury and District Community Hospital will require an MRSA screen prior to admission. This will also enable compliance with national guidance contained within the Darzi report and also Department of Health Publications. This process is best achieved through pre-admission assessment which allows enough time for MRSA decolonisation/suppression to be undertaken before admission. 2.0 OBJECTIVE/SUCCESS FACTOR This guidance sets out to ensure that staff working within surgical units in the PCT are informed and aware of who to screen, when to screen, how to screen and, dependent upon results, what treatment is required. It is not anticipated that screening and prescription of antimicrobial agents will lead to cancellation of surgery within the Trust. 3.0 LINKS TO OTHER KEY STRATEGIES & POLICIES This guidance should be read in conjunction with: a) Trust Infection Prevention and Control Guidance (particularly including guidance on personal protective clothing, hand hygiene and care and management of MRSA). b) Primary Care Antimicrobial Prescribing Guidance. c) Trust Infection Prevention and Control plans, position statements and strategy documents. 4.0 RESPONSIBILITIES General Staff Responsibilities it is the responsibility of all clinical staff working in surgical areas of the PCT to adhere to this guidance and report breaches to the nurse in charge or their line manager. Ward and Department Managers are responsible for ensuring implementation within their area, and for ensuring all staff who work within the area adhere to the principles at all times. This includes ensuring compliance during pre operative surgical assessment and care, intra operative and post operative care. Breaches should be investigated and reported as a clinical risk. Consultant Medical Staff are responsible for ensuring their junior staff read and understand this policy and appropriate antimicrobial suppression treatment and prophylaxis is given in compliance with antimicrobial prescribing guidance. The Infection Control Team is responsible for providing expert advice in accordance with this policy, for supporting staff in its implementation, and assisting with risk assessment where complex decisions are required. They are also responsible for ensuring this policy remains consistent with the evidence-base for safe practice, and for reviewing the policy on a regular basis. 5.0 WHO TO SCREEN: Appendix 1 details an explicit list of procedures undertaken and the requirement to screen. This is available in surgical areas as a laminated version. To summarise, the procedure list stipulates that all patients will require screening with the exception of: Day case ophthalmology procedures Dental Procedures Endoscopy procedures (Gastroscopy, sigmoidoscopy, colonoscopy, flexible cystoscopies, hysteroscopies etc) Minor dermatology procedures including those undertaken as minor surgery (eg vasectomies, removal of lumps and bumps, nail evulsions and in general minor excisional procedures which could be undertaken in GP practice) Gynae procedures such as D&C or coil insertion or those where there is no wound generated. Pain Clinic Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 3 of 12
4 The only time it may be necessary to screen patients attending for surgery who are normally excluded, as previous list, would be if they presented with the following risk factors: All patients admitted from the community presenting with invasive devices All patients transferred from another healthcare provider including care establishments such as nursing or residential homes All patients who are known to be a previous positive Patients who have had a hospital admission in the last 12 months Patients who are working in care procedures or who are providing care for relatives with MRSA 6.0 WHEN TO SCREEN To ensure that screens do not get missed, it is advised that they are undertaken as part of the routine pre-op process. As long as there is a valid screen within the last 28 days this will count towards the surgical screen. Please refer to Appendix 2 for algorithms relating to the screening process. 7.0 HOW TO SCREEN Because MRSA colonisation is asymptomatic it can only be identified by taking screening swabs from appropriate sites. Further details are provided within the samples guidance contained in the infection control policies and procedures binder. Screening swabs are to be taken from the following sites. As a minimum, three screening swabs need to be undertaken: anterior nares of the nose axillae groins In addition to the above, other areas which should be included in the screen are: any areas of broken, dry or damaged skin or wounds CSU if patient catheterised; All site(s) of invasive device(s) if present Sputum if productive cough Please note, as per current guidance, swabs used to sample dry skin sites must be moistened by applying drops of sterile water for injection or saline onto the cotton bud tip. It is imperative that care is taken to avoid contaminating either the cotton bud tip or shaft of the swab with your own skin flora or contaminants from the environment. All swabs must be clearly labelled with patient details and site of swab. All of the samples can go with just one microbiology form which in addition to the standard patient details and location must state, history in relation to MRSA, swabs which are enclosed, date and nature of elective procedure and any other relevant details including current antibiotics. All results will be returned to the requesting source. Please note, any unlabelled or unidentified specimens will not be processed and this may result in unnecessary treatment being prescribed. 8.0 TREATMENT With regard to patients requiring MRSA screening prior to elective surgical admission, the following treatment options should be followed to enable suppression of MRSA in a patient presenting with a single MRSA positive result from a screen: If a positive result is obtained. This will be unchanged from the current treatment guidance and will involve the following items which are contained on a PGD being prescribed for a period of a minimum of 5 days, to commence 5 days prior to the procedure being undertaken: Mupirocin 2% Nasal Ointment (Nasal Bactroban) for Mupirocin sensitive strains of MRSA. This should be applied to the inside of the nostrils (anterior nares) three times a day for a period of 5 days. Following application the sides of the nose should be pressed gently together to ensure the ointment is spread throughout the nostrils. For mupirocin resistant strains advice should be sought from the Infection Control Team. Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 4 of 12
5 Octenisan Antimicrobial Body Washes these are a daily wash. To promote effectiveness of this, it is recommended that a formal programme is adopted in each area ensuring that washes are carried out in the most effective manner. Octenisan should be used as a liquid soap and shampoo and the whole body should be washed vigorously from head to toe. Particular attention should be paid to the hair, around the nostrils, axillae, groins, perineum and feet. The antiseptic should be used neat on wet skin like a shower gel, left in contact with the skin for three minutes and then rinsed off. If bathing/showering is not possible then the antiseptic should be applied onto a wet body surface using a clean flannel, left in contact with the skin for three minutes and then rinsed off. Ideally over the period of 5 days, 2 hair washes should occur using this product. Chlorhexidine Acetate Dusting Powder (CX powder) Apply as a powder daily following washing, a light dusting should be dispensed to cover axillae, umbilicus and groin area. It should not be used on badly broken skin. In addition it may be necessary to prescribe systemic antibiotics if clinical signs and symptoms of infection are apparent and also consider the need for prophylaxis during the surgical procedure. If wounds are found to be colonised these require assessment and the use of an appropriate antimicrobial agent should be considered. This could include use of Mupirocin (Bactroban) ointment/cream, if sensitive or dressings that have a silver, iodine or honey base. These should be used in accordance with wound care product formulary guidance. If there has not been an opportunity to undertake a screen within a timeframe which allows 5 days of the above treatment to be prescribed prior to surgery on receipt of a positive result, then a screen must be taken at the earliest opportunity and the patient commenced on Octenisan Daily Body Washes as a precaution until the result is received. If this result is positive, they should then be commenced on 5 full days of suppression treatment. If the screen results are negative then treatment can cease. Staff working within the surgical area will be responsible for notifying patients of results in these circumstances. Generally speaking, surgery should not be delayed and ward staff should discuss individual cases with either the infection control nurses or consultant microbiologist. 9.0 DOCUMENTATION The MRSA status of all patients must be accurately recorded in medical and nursing notes, including information on topical decolonisation therapy and specimen results. This is the responsibility of the medical and nursing teams caring for the patient. It is essential to ensure safe, effective care COMMUNICATION AND PATIENT INFORMATION Patients and visitors must be provided with accurate information on MRSA. This is the responsibility of the medical and nursing team admitting or providing care for the patient. The information that should be given to all patients includes the risk of infection during procedures and, for those found to be positive, information on their care, treatment and management. Information leaflets are available to support this. Accurate information on MRSA status must be recorded and communicated to other wards and departments in order to facilitate safe care. This includes information on topical decolonisation and specimen results. It is essential that this is recorded and communicated to staff in primary and community care upon transfer to another organisation or discharge home. Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 5 of 12
6 11.0 COMPLIANCE 100% compliance with this policy is expected, and the PCT is required to assure itself, its patients, commissioners and the Department of Health that this is being achieved. Surgical areas must therefore ensure that robust processes are in place to ensure that all elective patients who require screening are screened for MRSA in as timely a manner as possible and that the results of those screens are acted upon appropriately KEY POINTS 12.1 Overview Consider the risk of MRSA as a potential pathogen and prescribe appropriate antimicrobial therapy or surgical prophylaxis when indicated Surveillance will be performed in order to monitor trends in MRSA and facilitate prevention and control measures 12.2 MRSA Screening Screen patients by taking specimens from the correct sites, and labelling them correctly Screening of certain patients prior to elective surgical procedures Treatment Prescribe and administer MRSA topical decolonisation therapy correctly in line with policy Ensure patients who are MRSA positive prior to admission for surgical elective procedures receive appropriate suppression/decolonisation treatment/therapy; either to reduce the bioburden and risk of infection or eradicate MRSA Documentation Ensure the MRSA status of all patients is accurately recorded, including information on topical decolonisation and specimen results. This can assist in informing all future healthcare. It is imperative that a result is not considered as current if not taken within 4 weeks preceding the procedure REFERENCES Coia JE, Duckworth GJ, Edwards DI, et al (2006) Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities by the Joint BSAC/HIS/ICNA Working Party on MRSA. Journal of Hospital Infection. 63 (Supplement 1) Department of Health High quality care for all: NHS Next Stage Review final report. _ Department of Health MRSA screening - operational guidance Department of Health Screening for Meticillin Resistant Staphylococcus aureus (MRSA) colonisation: a strategy for NHS trusts - a summary of best practice. H_ Department of Health. PL CMO (2006)4: Screening for MRSA colonisation: a summary of best practice. icalofficerletters/dh_ Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 6 of 12
7 APPENDIX 1 LIST DETAILING PROCEDURES AND REQUIREMENT FOR MRSA SCREENING MRSA Screening required? DESCRIPTION OF PROCEDURE Yes = No = DENTAL SURGERY Surgical removal of tooth Simple extraction of tooth Excision of dental lesion of jaw Orthodontic operations ENDOSCOPIC PROCEDURES Fibreoptic endoscopic procedures Diagnostic fibreoptic endoscopic procedures Diagnostic endoscopic examination of colon Endoscopic extirpation of lesion of colon Extirpation/lesion/lower bowel using fibreoptic sigmoidoscope Diagnostic examination of lower bowel with fibreoptic sigmoidoscope Therapeutic endoscopic operations on peritoneum GENERAL SURGERY Fixation of rectum for prolapse Perineal operations for prolapse of rectum Excision of lesion of anus Excision of haemorrhoid Dilation of anal sphincter Other operations on perianal region Other operations on anus Excision of pilonidal sinus Other operations on pilonidal sinus Excision of skin lesion Removal of inorganic substance from skin Removal of other substance from skin Opening of skin Primary repair of inguinal hernia Primary repair of femoral hernia Primary repair of umbilical hernia Primary repair of incisional hernia Repair of other hernia of abdominal wall Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 7 of 12 If minor no all others yes Other operations on soft tissue Repair of muscle (abdomen) In the event of a positive result being obtained please contact the Infection Control Nurses or Consultant Microbiologist for further information
8 DESCRIPTION OF PROCEDURE GYNAECOLOGY Vaginal operations to support outlet of female bladder: TVT/repair Operations on bartholin gland Excision of vulva (skin tags/warts) Extirpation of lesion of vulva Other operations on vulva Operations on female perineum Operations on introitus of vagina Extirpation of lesion of vagina Other operations on Vagina Excision of cervix/uterus/hysterectomy Biopsy of cervix uterus Other operation on cervix Abdominal excision of uterus Vaginal excision of uterus Introduction/replacement of intrauterine contraceptive device Removal of intrauterine contraceptive device Therapeutic endoscopic operations on uterus Diagnostic endoscopic examination of uterus Unilateral salpingo oophorectomy Other excision of adnexa of uterus Partial excision of fallopian tubes Endoscopic bilateral occlusion of fallopian tubes lap sterilisation Other endoscopic operations on fallopian tubes Therapeutic endoscopic operations on ovary Other examination of female genital tract Repair of muscle (abdomen) ORTHOPAEDIC Excision of ganglion Operations on Bursa Manipulation of spine Complex reconstruction of forefoot MRSA Screening Required? YES = No = Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 8 of 12 If minor no all others yes Only screen if wound Total excision of bone Other excision of bone In the event of a positive result being obtained please contact the Infection Control Nurses or Consultant Microbiologist for further information
9 ORTHOPAEDIC Continued Division of bone in foot Other internal fixation of bone Diagnostic puncture of bone Excision reconstruction of joint Fusion of joint of toe DESCRIPTION OF PROCEDURE Other primary fusion of other joint Other open operations on intra-articular structure. Stabilising operations on joint Release of contracture of joint Soft tissue operations on joint of toe Open debridement and irrigation of joint Other open operations on joint Therapeutic endoscopic operations on cavity of knee joint (arthroscopy) Diagnostic endoscopic examination of knee joint (arthroscopy) Puncture of joint Amputation of toe Carpal tunnel release Release of entrapment of peripheral nerve at wrist or other site Extirpation of lesion of peripheral nerve Other operations on peripheral nerve Excision of other fascia Release of fascia Transposition of tendon Freeing of tendon Excision of tendon Other operations on sheath of tendon Repair of muscle (limbs) Therapeutic endoscopic operations on semilunar cartilage Therapeutic endoscopic operations on other articular cartilage Excision of nail bed Total excision of nail Other operations on nail MRSA Screeings Required? YES = No - If minor no all others yes In the event of a positive result being obtained please contact the Infection Control Nurses or Consultant Microbiologist for further information Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 9 of 12
10 PAIN CLINIC Epidural injection Operations on spinal nerve root Destruction of peripheral nerve DESCRIPTION OF PROCEDURE Cryotherapy to sympathetic nerve Radiofrequency controlled thermal destruction of sympathetic nerve Other operations on sympathetic nerve Introduction of therapeutic substance into subcutaneous tissue Denervation of spinal facet joint of vertebra UROLOGY Endoscopic dilation of ureter Endoscopic extirpation of lesion of bladder Endoscopic operations to increase capacity of bladder Diagnostic endoscopic examination of bladder Other operations on bladder Operations on outlet of female bladder Therapeutic endoscopic operations on urethra Other operations on Urethra Other excision of testis Operations on hydrocele sac Operations on epididymis Bilateral vasectomy Excision of lesion on penis Frenuplasty of penis Circumcision MRSA Screeings Required? YES = No - If minor no all others yes Other operations on penis In the event of a positive result being obtained please contact the Infection Control Nurses or Consultant Microbiologist for further information REFERENCES Department of Health MRSA screening - operational guidance. Department of Health Screening for Meticillin Resistant Staphylococcus aureus (MRSA) colonisation: a strategy for NHS trusts - a summary of best practice. Department of Health. PL CMO (2006)4: Screening for MRSA colonisation: a summary of best practice Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 10 of 12
11 APPENDIX 2 PCT Algorithm for Regular Attendees Initial Screen at first appointment or on presentation at clinic or out patient departments prior to invasive device insertion (nose, groin, and axilla as a minimum and wounds, invasive devices, including CSU if catheter insitu). Please note these results can be instrumental in future management Result Negative Result Positive Re-screen in approximately 18 weeks Decolonisation Successful No more than 2 attempts at decolonisation prior to a procedure. Adhere to 5 day treatment plan and rescreen on day 7 Decolonisation Not Successful Consider Suppression Therapy implemented 5 days prior to procedure. NOTE: The screening process should not delay the undertaking of scheduled procedures. Due to regular attendance and to minimise inconvenience to patients, the initial screen can be undertaken in clinic with results used to inform future management. Contact Infection Control Nurses for further information on Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 11 of 12
12 PCT Algorithm for Elective Surgical Admissions Screen at pre op/admission clinic/out-patient department if indicated on PCT list (nose, groin and axilla, wounds, invasive devices, include CSU if catheter insitu Result Negative Result Positive Proceed to Surgery Proceed to Surgery starting decolonisation therapy for suppression of MRSA level 5 days prior to surgery If indicated consider preop glycopeptide prophylaxis NOTE: If it is not possible to screen with sufficient time for 5 day course of treatment prior to admission, particularly when operation is scheduled due to cancellation etc. The screen must be undertaken and patient commenced on Octenisan Daily Body Washes as suppression/decolonisation therapy to enable a maximum of 5 days prior to the procedure. If negative screen results are obtained then this can stop, if a positive result is obtained then the full 5 day decolonisation/suppression treatment (Octenisan, CX powder and Nasal preparation should be prescribed via PGD), this will obviously be for a period of 5 days, some of which will be post op. There will generally be no requirement to re-screen. This need for this will be assessed on an individual basis through liaison with the Infection Control Nurses who can be contacted on Guidelines for MRSA Screening in Relation to Elective Surgical Admissions 19/03/2009 Page 12 of 12
Hereford Hospitals NHS Trust
Hereford Hospitals NHS Trust Universal Meticillin Resistant Staphylococcus Aureus (MRSA) Screening Protocol IC.08 IF THIS DOCUMENT HAS BEEN PRINTED, IT SHOULD NOT BE ASSUMED TO BE THE LATEST VERSION. Document
More informationMETICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change
METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE First Issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date 10/2008 1 Guidance
More informationInfection Prevention Control Team
Title Document Type MRSA Policy for NHS Borders Policy Version Number 4.0 Approved by Infection Control Committee Issue date June 2014 Review date June 2017 Distribution Prepared by Developed by All NHS
More informationPatient Demographic / Label. Infection Control Care Plan for a patient with MRSA
Patient Demographic / Label Infection Control Care Plan for a patient with MRSA Statement: This Care Plan should be used with patients who are suspected of or are known to have MRSA. This Care Plan should
More informationPatient Information Service. Infection prevention and control department MRSA
Southend University Hospital NHS Foundation Trust Patient Information Service Infection prevention and control department MRSA Meticillin-resistant Staphylococcus aureus This is an information leaflet
More informationPolicy Objective To provide Health Care Workers (HCWs) with details of the precautions necessary to minimise the risk of MRSA cross-infection.
Page 1 of 16 Policy Objective To provide Health Care Workers (HCWs) with details of the precautions necessary to minimise the risk of MRSA cross-infection. This policy applies to all staff employed by
More informationMethicillin Resistant Staphylococcus aureus (MRSA) screening and decolonisation
Information for patients and carers This leaflet can be made available in other formats including large print, CD and Braille and in languages other than English, upon request. Contents Page What is MRSA?
More informationTrust Policy, Infection Control
Trust Policy, Infection Control Title: Methicillin Resistant Staphylococcus Aureus () and Methicillin Sensitive Staphylococcus Aureus (MSSA) Screening and Infection Control Management Policy. (Key Words:,
More informationMRSA. Information for patients Infection Prevention and Control. Large Print
MRSA Information for patients Infection Prevention and Control Large Print page 2 of 16 What is MRSA? MRSA is a bacterium (germ), which can be found living on the skin of healthy individuals, particularly
More informationMRSA. Information for patients Infection Prevention and Control
MRSA Information for patients Infection Prevention and Control What is MRSA? MRSA is a bacterium (germ), which can be found living on the skin of healthy individuals, particularly in the lining of the
More informationThe Clatterbridge Cancer Centre. NHS Foundation Trust MRSA. Infection Control. A guide for patients and visitors
The Clatterbridge Cancer Centre NHS Foundation Trust MRSA Infection Control A guide for patients and visitors Contents Information... 1 Symptoms... 1 Diagnosis... 2 Treatment... 2 Prevention of spread...
More informationMeticillin Resistant Staphylococcus Aureus (MSRA) for Community Settings Policy
Meticillin Resistant Staphylococcus Aureus (MSRA) for Community Settings Policy Author(s) & Designation Lead Clinician if appropriate In consultation with To be read in association with Ratified by Suzanne
More informationMethicillin Resistant Staphylococcus aureus (MRSA) Procedure
Document title: Document number: Staff involved in Development (job titles): Document author/owner: Directorate: Department: For use by: Methicillin Resistant Staphylococcus aureus (MRSA) Procedure DN339
More informationSkin and Nasal Decolonization for Adult
01.30.02 Skin and Nasal Decolonization for Adult Purpose A. Patient Population Included: B. Process for Obtaining and Processing Specimen C. Procedure for Notification of MRSA/MSSA Positive Samples To
More informationMRSA: Help us to help to help you
MRSA: Help us to help to help you Information on MRSA within The Queen Elizabeth Hospital 1 At QE Gateshead we are committed to reducing the risk of infection. What is MRSA? There are many different types
More informationMRSA Policy Best Practice Guidelines. Printed copies must not be considered the definitive version. August 2017 Scope. Infection Control Team
MRSA Policy Best Practice Guidelines Printed copies must not be considered the definitive version DOCUMENT CONTROL Policy Group POLICY NO. Infection Control Committee Author Ross Darley Version no. 3 Reviewer
More informationWhat you can do to help stop the spread of MRSA and other infections
MRSA wash it away As a patient it is important that you get better quickly and stay well. This leaflet gives you information about MRSA and other health care associated infections, so that you know what
More informationPatient Information Service. Infection prevention and control department MRSA
Patient Information Service Infection prevention and control department MRSA Meticillin-resistant Staphylococcus aureus This is an information leaflet to help explain MRSA SOU859_054394_0116_V1.indd 1
More informationMethicillin-Resistant Staphylococcus aureus Health and Social Care Act 2010 Contributes to CQC Core Standard Outcome 8
Prevention and Management of Methicillin-Resistant Staphylococcus aureus (MRSA) Clinical Guidelines Register No: 04075 Status: Public Developed in response to: Guidelines for the Control and Prevention
More informationCommunity Infection Prevention and Control Guidance for Health and Social Care
Community Infection Prevention and Control Guidance for Health and Social Care Version 1.02 August 2017 Harrogate and District NHS Foundation Trust 16 August 2017 Version 1.02 Page 1 of 13 Please note
More informationMRSA INFORMATION LEAFLET for patients and relatives. both in hospital and the community. MRSA is a type of
MRSA INFORMATION LEAFLET for patients and relatives WHAT DOES MRSA STAND FOR? Meticillin Resistant Staphylococcus aureus. WHAT IS MRSA? Staphylococcus aureus is a germ that is commonly found both in hospital
More informationMRSA. Information for patients and carers. Delivering the best in care. UHB is a no smoking Trust
MRSA Information for patients and carers Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationClinical Director for Women s and Children s Division
PREVENTION AND MANAGEMENT OF MRSA (METHICILLIN RESISTANT STAPHLOCOCCUS AUREUS) IN MATERNITY CLINICAL GUIDELINES Register No: 07002 Status: Public Developed in response to: Contributes to CQC Standard No:
More informationMRSA Management of patients with meticillin-resistant staphylococcus aureus. Ref IPC v3. Status: Approved Document type: Procedure
MRSA Management of patients with meticillin-resistant staphylococcus aureus Ref IPC-0001-009 v3 Status: Approved Document type: Procedure Contents 1. Purpose... 3 2. Related documents... 3 3. Management
More informationand colonisation suppression POLICIES REPLACING N/A
TITLE: UNIQUE IDENTIFIER Assigned by Sharepoint VERSION No 1.2 LEAD AUTHOR S NAME Allison Charlesworth LEAD AUTHOR JOB TITLE Matron Infection Prevention ACCOUNTABLE DIRECTOR Rob Dearden, Director of Nursing
More informationMETICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): CONTROL AND PREVENTION
INFECTION CONTROL POLICY METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): CONTROL AND PREVENTION DOCUMENT REF: PICCMRSA (Version No. 3.0) Name and designation of policy author(s) Approved by (committee,
More informationCommunity Infection Prevention and Control Guidance for Health and Social Care
Community Infection Prevention and Control Guidance for Health and Social Care MRSA Version 1.00 October 2015 Cumbria County Council MRSA October 2015 Version 1.00 Harrogate and District NHS Foundation
More informationMETICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): CONTROL AND PREVENTION
INFECTION CONTROL POLICY METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): CONTROL AND PREVENTION DOCUMENT REF: PICCMRSA (Version No. 2.0) Name and designation of policy author(s) Approved by (committee,
More informationPolicy for the control and management of patients colonised or infected with Meticillin Resistant Staphylococcus aureus (MRSA)
Policy for the control and management of patients colonised or infected with Meticillin Resistant Staphylococcus aureus (MRSA) Author: Responsible Lead Executive Director: Endorsing Body: Infection Prevention
More informationPrevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015
Prevention and Control of Infection in Care Homes Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Content for today Importance of IPAC -refresher IPAC audits in
More informationThe Management of Patients with Meticillin Resistant Staphylococcus Aureus Policy (MRSA)
The Management of Patients with Meticillin Resistant Staphylococcus Aureus Policy (MRSA) This policy identifies the key processes and protocols for patients colonised or infected with meticillin resistant
More information: Hand. Hygiene Policy NAME. Author: Policy and procedure. Version: V 1.0. Date created: 11/15. Date for revision: 11/18
: Hand NAME Hygiene Policy Target Audience Author: Type: Clinical staff BD Policy and procedure Version: V 1.0 Date created: 11/15 Date for revision: 11/18 Location: Dropbox/website Hand Hygiene Policy
More information& PVL Staphylococcus aureus (PVL-SA) Policy
Section T Meticillin-resistant Staphylococcus aureus (MRSA) & PVL Staphylococcus aureus (PVL-SA) Policy Version 9 Important: This document can only be considered valid when viewed on the Trust s Intranet.
More informationManagement of Meticillin Resistant Staphylococcus aureus (MRSA)
Infection Prevention and Control Guideline no 14 Management of Meticillin Resistant Staphylococcus aureus (MRSA) This document has been updated following the recommendation of the NOW report. Approved
More informationinfection control MRSA Information for patients (Methicillin Resistant Staphylococcus aureus)
infection control MRSA (Methicillin Resistant Staphylococcus aureus) Information for patients What is MRSA and why is it a problem in the hospital? Many of us carry bacteria called Staphylococcus aureus
More informationSection G - Aseptic Technique. Version 5
Section G - Aseptic Technique Version 5 Important: This document can only be considered valid when viewed on the Trust s Intranet. If this document has been printed or saved to another location, you must
More informationProcedures for Prevention and Management of MRSA / Carbapenemase-producing Enterobacteriaceae (Antimicrobial Resistance) in Care Settings in Shetland
Procedures for Prevention and Management of MRSA / Carbapenemase-producing Enterobacteriaceae (Antimicrobial Resistance) in Care Settings in Shetland Adapted from: Grampian NHS Board Policies 2007, and
More informationCarbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas
Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas This toolkit includes examples advice leaflets and forms which may be helpful for use by teams or
More informationDocument Title: MRSA Policy. Document No. EDRMS000061C Version No. 1.0 replaces version 6. Approved by Clinical PAG Date approved 21/09/2012
MRSA Policy Document No. EDRMS000061C Version No. 1.0 replaces version 6 Approved by Clinical PAG Date approved 21/09/2012 Ratified by Patient Safety and Quality Committee Date ratified 02/10/2012 Date
More informationMeticillin- Resistant Staphylococcus aureus (MRSA) Policy
Meticillin- Resistant Staphylococcus aureus (MRSA) Policy Policy Number / Version: Ratified by: 7.16 v2 Trust Board Date ratified: 31 st March 2009 Name of originator/author: Name of responsible committee/individual:
More informationA guide for patients and visitors MRSA. A guide for patients and visitors
MRSA A guide for patients and visitors 1 The purpose of this leaflet is to provide information to you and your family about MRSA. The word bacteria has been used in this leaflet to describe commonly used
More informationDisclosure Status (B) B Can be disclosed to patients and the public
Policy: ICP12 MRSA Policy Version: ICP12/V7 Ratified by: Trust Management Team Date ratified: 11 March 2015 Title of Author: Infection Control Nurse Title of responsible Director Director of Nursing &
More informationASEPTIC TECHNIQUE LEARNING PACKAGE
ASEPTIC TECHNIQUE LEARNING PACKAGE Staff Name:... Date:... Table of Contents What is Aseptic technique? 3 Core infection control components 3 Key parts 5 References 6 Aseptic technique questionnaire 7
More informationTrust Policy. Policy for the Control of Meticillin Resistant Staphylococcus Aureus (MRSA) Vickie Longstaff (Nurse Consultant)
Trust Policy Policy for the Control of Meticillin Resistant Staphylococcus Aureus (MRSA) Author(s) Version Vickie Longstaff (Nurse Consultant) 7 (Update of 2011 version) Version Date September 2013 Implementation/approval
More informationEnhanced recovery programme
Enhanced recovery programme Gynaecological surgery Information for patients Gynaecology The aim of this leaflet is to provide you and your family with an understanding of enhanced recovery. This will prepare
More informationHealthcare-Associated Infections
Healthcare-Associated Infections A healthcare crisis requiring European leadership Healthcare-associated infections (HAIs - also referred to as nosocomial infections) are defined as an infection occurring
More informationReducing the risk of healthcare associated infection
i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can
More informationInfection Prevention. & Control. Report
Infection Prevention & Control Report April 2012 March 2013 Author Joanne Raper, Infection Prevention & Control Nurse Manager Page 1 of 10 1.0 Purpose of the Paper The purpose of this report is to provide
More informationPolicy Number F9 Effective Date: 17/07/2018 Version: 3 Review Date: 17/07/2019
Aim of the Policy This document outlines the policy of Carefound Home Care (the Company ) in relation to infection control. Infection control is the name given to a wide range of policies, procedures and
More informationApproval Signature: Date of Approval: December 6, 2007 Review Date:
Personal Care Home/Long Term Care Facility Infection Prevention and Control Program Operational Directive Management of Methicillin-Resistant Staphylococcus Aureus (MRSA) Approval Signature: Supercedes:
More informationHealth Professionals (NMAHPs) Lanarkshire Infection Control Committee (LICC) Emer Shepherd, Head of Infection Prevention and Control
Policy for the investigation, control and management of patients colonised or infected with Panton-Valentine Leukocidin (PVL) - Meticillin sensitive Staphylococcus aureus (MSSA) and Meticillin Resistant
More informationInfection Prevention Guidance: MRSA: Screening and Management of Patients with MRSA
Infection Prevention Guidance: MRSA: Screening and Management of Patients with MRSA (Including Panton-Valentine Leukocidin (PVL) MRSA) Reference No: Version: 3.1 Ratified by: G_IPC_20 LCHS Trust Board
More informationChapter 10. medical and Surgical Asepsis. safe, effective Care environment. Practices that Promote Medical Asepsis
chapter 10 Unit 1 Section Chapter 10 safe, effective Care environment safety and Infection Control medical and Surgical Asepsis Overview Asepsis The absence of illness-producing micro-organisms. Asepsis
More informationPolicy for use of the Royal Marsden Manual of Clinical Nursing Procedures (9th Edition)
Policy for use of the Royal Marsden Manual of Clinical Nursing Procedures (9th Edition) Document Summary This Policy defines the clinical procedures for all Clinical staff (including temporary staff, contracted
More informationMRSA in Holland What is Behind the Success Gertie van Knippenberg-Gordebeke
MRSA situations in Holland: What is behind the success? ICP, VieCuri Medical Centre Venlo, The Netherlands Hosted by Paul Webber paul@webbertraining.com www.webbertraining.com INFECTION CONTROL HISTORY
More informationEveryone Involved in providing healthcare should adhere to the principals of infection control.
Infection Control Introduction The prevention and control of infection is an integral part of the role of all health care personnel. Healthcare Associated Infections (HCAIs) affect an estimated one in
More informationReducing the risk of healthcare associated infection
i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can
More informationHysterectomy. What is a hysterectomy? How is this procedure done?
Hysterectomy What is a hysterectomy? A hysterectomy is a surgery that removes your uterus (womb). The uterus is one of the organs of the female reproductive system. It is about the size of your closed
More information(MRSA) De-isolation Procedure
Methicillin-Resistant Staphylococcus aureus (MRSA) De-isolation Procedure Updated December 2012 OHSU Department of Infection Prevention and Control Anna Schappacher Brown RN OHSU SON Master of Public Health
More informationNorthumbria Healthcare NHS Foundation Trust. Infection Control Information for Patients and Visitors. Issued by The Infection Control Team
Northumbria Healthcare NHS Foundation Trust Infection Control Information for Patients and Visitors Issued by The Infection Control Team Introduction The purpose of this leaflet is to help you understand
More informationNOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION
NOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION DR AHMAD SHALTUT OTHMAN JAB ANESTESIOLOGI & RAWATAN RAPI HOSP SULTANAH BAHIYAH ALOR SETAR, KEDAH Nosocomial infection Nosocomial or hospital
More informationRegions Hospital Delineation of Privileges Family Medicine
Regions Hospital Delineation of Privileges Family Medicine Applicant s Name: Last First M. Instructions: Place a check-mark where indicated for each core group you are requesting. Review education and
More informationDirect cause of 5,000 deaths per year
HOSPITAL ACQUIRED (NOSOCOMIAL) INFECTION Policies MRSA Policy Meningitis Policy Blood and body fluid Exposure Policy Disinfection Policy Glove Policy Tuberculosis Policy Isolation Policy DEFINITION: ANY
More informationASEPTIC TECHNIQUE POLICY
SECTION 3b ASEPTIC TECHNIQUE POLICY INFECTION CONTROL MANUAL Read in conjunction with: o Hand hygiene policy (also section 3) o Standard (Universal) Precautions policy (section 4) o Decontamination policy
More informationTenckhoff Catheter Insertion
Tenckhoff Catheter Insertion Information for patients with chronic kidney disease (CKD) who have chosen to have peritoneal dialysis Renal Directorate Produced: May 2010 Review date: May 2012 This leaflet
More informationPROCEDURE FOR TAKING A WOUND SWAB
CLINICAL PROCEDURE PROCEDURE FOR TAKING A WOUND SWAB Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date 2 To provide a standardised process of the fundamental principles
More informationTRUST BOARD. Date of Meeting: 05/10/2010
TRUST BOARD Date of Meeting: 05//20 Enclosure: 7 Agenda Item No: 8.3 Title of Report: Interim Report for Infection Prevention and Control 20-2011 Aims: To inform the Board of the work of the Trust in controlling
More informationTRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO)
TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO) Reference Number POL- IC/1082/14 Version 1.2.0 Status Final Author: Helen Forrest
More informationPOLICY FOR TAKING BLOOD CULTURES
Sponsor: Reviewer(s): Dr Roberta Parnaby (Consultant Microbiologist) Dr Alicja Baczynska (F2 Microbiology) Dr Chris Gordon (Medical Director) Dr Roberta Parnaby Dr Matthew Dryden (Consultant Microbiologists)
More informationFamily Practice with Enhanced Surgical Skills Clinical Privileges
Name: Effective from / / to / / Initial privileges (initial appointment) Renewal of privileges (reappointment) All new applicants should meet the following requirements as approved by the governing body,
More informationOvarian Tumor Reduction Surgery
PATIENT EDUCATION patienteducation.osumc.edu Information About Your Your doctor found a mass in your pelvic area. Surgery is used to remove the pelvic mass and to find out if the tissue is benign (not
More informationMRSA Meticillin-resistant
MRSA Meticillin-resistant Staphylococcus aureus Information leaflet for patients and visitors What is MRSA? MRSA is meticillin (previously known as methicillin) resistant Staphylococcus aureus. Staphylococcus
More informationBest Practice Guidelines BPG 5 Catheter Care
Best Practice Guidelines BPG 5 Catheter Care BGP 5 1 DOCUMENT STATUS: Reviewed DATE ISSUED: March 2014 DATE TO BE REVIEWED: 13.10.17 AMENDMENT HISTORY VERSION DATE AMENDMENT HISTORY V1 March 2014 New Guideline
More informationHOSPITAL EPIDEMIOLOGY AND INFECTION CONTROL: SURGICAL SITE INFECTION REPORTING TO CALIFORNIA DEPARTMENT OF PUBLIC HEALTH
Office of Origin: Department of Hospital Epidemiology and Infection Control (HEIC) I. PURPOSE To comply with reporting cases of surgical site infection as required by Sections 1255.8 and 1288.55 the California
More informationNURSING GUIDELINE ON PERFORMING A WOUND SWAB
NURSING GUIDELINE ON PERFORMING A WOUND SWAB Version Number 3 Date of Issue 9 th January 2014 Reference Number Review Interval NGPWS-12-2013-CH-V3 3 yearly or more regularly if international evidence indicates
More informationInfection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases
Infection Prevention Infection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases to yourself, family members,
More informationANTERIOR RESECTION WHAT ARE THE BENEFITS OF HAVING AN ANTERIOR RESECTION?
WHAT IS AN ANTERIOR RESECTION? ANTERIOR RESECTION This is an operation that is designed to remove part of your lower large bowel and then join the bowel ends back together again. This is called an anastamosis.
More informationDeveloped in response to: Best Practice Infection Prevention and Control
Transfer of patients within MEHT Clinical Guideline Developed in response to: Best Practice Infection Prevention and Control Version Number 1.0 Issuing Directorate Corporate Governance Approved by Clinical
More informationRADICAL REMOVAL OF THE KIDNEY AND URETER
Procedure Specific Information What is the evidence base for this information? This publication includes advice from consensus panels, the British Association of Urological Surgeons, the Department of
More informationPreventing Infection in Care
Infection Prevention and Control: Older Person Care Homes & Home Environment Learning Programme Workbook NHS Education for Scotland 2011. You can copy or reproduce the information in this document for
More informationTop copy accepted by patient: yes/no (please ring)
Consent Form 3 Patient / Parental agreement to investigation or treatment Procedures where consciousness not impaired Name of proposed procedure or course of treatment Hospital NHS Surname no: no: OUTPATIENT
More informationTreating a Bartholin s cyst or abscess
Treating a Bartholin s cyst or abscess The aim of this information leaflet is to help answer some of the questions you may have about the treatment of a Bartholin s cyst or abscess. If you have any questions
More information01/09/2014. The very first requirement in a hospital is that it should do the sick no harm!!!!
Infection Prevention and Control A Foundation Course Update on recent Guidelines and Recommendations Ros Cashman Cork University Maternity Hospital, Cork 2014 The very first requirement in a hospital is
More informationBlackpool CCG Governing Body Part I
2 August 2016 Prioritising the Use of Resources Background Governing Body members are aware of the huge growing pressures on NHS finances nationally and locally. This is primarily due to the slowing down
More informationYour operation in the Day Case Unit
INFORMATION FOR PATIENTS Your operation in the Day Case Unit Welcome to King s Mill Hospital This leaflet has been designed to help you to prepare for your admission to hospital. It is important that you
More informationLightning Overview: Infection Control
Lightning Overview: Infection Control Gary Preston, PhD, CIC, FSHEA Terry Caton, CIC Carla Ward, CIC 2012 Healthcare Management Alternatives, Inc. Objectives At the end of this module you will know: How
More informationStudent Nurses. Kenepuru Operating Theatres
Student Nurses Kenepuru Operating Theatres Tracey Doyle Page 1 2/3/2016 Kia Ora We are looking forward to working with you. Kenepuru Peri-operative Unit consists of Admission and Discharge areas, three
More informationHAND HYGIENE. The most up to date version of this policy can be viewed at the following website:
Page Page 1 of 16 Policy Objective To ensure that Healthcare Workers (HCWs) understand the importance of and their responsibilities in complying with this hand hygiene policy. To provide HCWs with an environment
More informationDepartment of Neurosurgery. Pre-operative Assessment Clinic Information for patients
Department of Neurosurgery Pre-operative Assessment Clinic Information for patients Before you come in for your operation you will be asked to come to the Pre-operative Assessment Clinic. These clinics
More informationTrust Policy METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS
Trust Policy For METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS A policy recommended for use In: All Clinical settings By: Staff who are caring for patients in clinical settings For: All patients Key Words:
More informationInfection Prevention and Control. Carbapenemase Producing Enterobacteriaceae (CPE)
Infection Prevention and Control Carbapenemase Producing Enterobacteriaceae (CPE) IPCT CPE Policy V4 May 2018 Policy Title: Executive Summary: Carbapenemase Producing Enterobacteriaceae (CPE) This policy
More informationNational Hand Hygiene NHS Campaign
National Hand Hygiene NHS Campaign Compliance with Hand Hygiene - Audit Report Your Questions Answered Germs. Wash your hands of them Prepared for the Scottish Government Health Directorate HAI Task Force
More informationNorth York General Hospital Policy Manual
TITLE: ASEPTIC TECHNIQUE (NON-OPERATING ROOM) CROSS REFERENCE: ORIGINATOR: Manager, IPAC APPROVED BY: Medical Advisory Committee ORIGINAL DATE APPROVED: Dec. 13, 2011 Operations Committee ORIGINAL DATE
More informationSECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS (VRE)
SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS () Introduction Definitions Associated with Risk Groups Signs and Symptoms Source Mode of Transmission Diagnosis Treatment Screening Transport Communication
More informationWRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT
WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT 2006-2007 Author(s) Gill Harris, Director of Infection Prevention and Control EXECUTIVE
More informationMRSA and Nursing homes: Is there a problem and do we need to change our guidelines?
MRSA and Nursing homes: Is there a problem and do we need to change our guidelines? Dr. C. SUETENS, B. JANS, Scientific Institute of Public Health, Epidemiology, Dr. O. DENIS, Prof. M. STRUELENS, National
More informationHand Hygiene Policy. Policy PH 06. Date June Page 1 of 19
Hand Hygiene Policy Policy PH 06 Date June 2007 Page 1 of 19 Document Management Title document Type document Description of of Hand Hygiene Policy Policy PH 06 Hand decontamination is the single most
More informationInspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust
Inspecting Informing Improving Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust December 2008 Outcome of inspection for: Hospital(s) visited: West Hertfordshire Hospitals NHS Trust
More informationEnhanced Recovery: Measurement for Improvement Monthly Data Submission Guidance. Version 1.0
Enhanced Recovery: Measurement for Improvement Monthly Data Submission Guidance Version 1.0 Document Control Version Version 1.0 Date Issued January 2014 Document To provide guidance for the monthly collection
More informationSkin Tunnelled Catheter (STC), also known as Central line
Skin Tunnelled Catheter (STC), also known as Central line Intravenous Therapy Department Patient information leaflet What is a skin tunnelled catheter? A skin tunnelled catheter (STC) is a long flexible
More information